Most ovarian cysts are not cancerous. The vast majority are functional cysts that form during normal ovulation and resolve on their own within a few menstrual cycles. But when a cyst looks unusual on imaging, persists after menopause, or comes with certain symptoms, your doctor will run tests to rule out malignancy. There’s no single test that gives a definitive answer before surgery. Instead, doctors piece together clues from ultrasound features, blood work, your age, and your risk factors to estimate how likely a cyst is to be cancerous.
What Ultrasound Features Raise Concern
Ultrasound is the first and most important tool for evaluating an ovarian cyst. What matters most isn’t the cyst’s size alone but its internal structure. A simple, fluid-filled cyst with thin, smooth walls is almost always benign. A cyst that contains solid tissue, thick internal walls, or irregular features warrants closer evaluation.
An international classification system called the IOTA Simple Rules identifies specific features that suggest malignancy:
- Irregular solid areas within the cyst
- Four or more papillary projections, which are finger-like growths extending inward from the cyst wall
- A large, irregular mass with multiple compartments exceeding 10 cm
- Free fluid in the abdomen (ascites), which can signal cancer has spread beyond the ovary
- Strong blood flow within the solid parts of the mass, detected by Doppler ultrasound
Radiologists also use a scoring system called O-RADS, which rates ovarian masses on a scale from 0 to 5 based on their ultrasound appearance. A score of 1 means the finding is normal. Scores of 4 or 5 indicate a higher risk of malignancy and typically lead to referral to a gynecologic oncologist. The more of these concerning features a cyst has, the higher the estimated risk.
Simple ovarian cysts, even in postmenopausal women, carry an extremely low cancer risk. A systematic review found the malignancy rate for simple cysts after menopause was roughly 1 in 10,000. So if your ultrasound report describes a simple, thin-walled, fluid-filled cyst, the chance of cancer is near zero regardless of your age.
Blood Tests and Their Limits
When an ultrasound looks suspicious, your doctor will likely order a blood test for CA-125, a protein that tends to be elevated in ovarian cancer. This test is useful but far from perfect. Plenty of non-cancerous conditions raise CA-125 levels, including endometriosis, uterine fibroids, pelvic inflammatory disease, liver disease, menstruation, and pregnancy. A high result doesn’t mean you have cancer, and a normal result doesn’t guarantee you don’t.
CA-125 is most reliable in postmenopausal women, where fewer benign conditions interfere with the result. In premenopausal women, elevated levels are more often caused by something other than cancer. Your doctor will interpret the number alongside your ultrasound findings and overall clinical picture rather than relying on it as a standalone answer.
Symptoms That May Signal Something More Serious
It’s worth being honest about a frustrating reality: symptoms alone cannot distinguish a cancerous cyst from a benign one. The two conditions overlap significantly. Both can cause pelvic pain, bloating, pressure, a frequent urge to urinate, and pain during sex.
That said, ovarian cancer tends to produce symptoms that are more persistent and harder to explain. Watch for bloating that doesn’t come and go but stays for weeks, unexplained weight loss, increasing fatigue, changes in bowel habits like new constipation, and lower back pain. These symptoms are common in many harmless conditions too, but when several appear together and don’t resolve, they deserve medical attention. A benign cyst is more likely to cause sharp, intermittent pain, especially if it ruptures or twists, while cancer symptoms tend to build gradually.
When MRI Adds Clarity
If an ultrasound can’t clearly determine whether a mass is benign or malignant, MRI is the next step. MRI is better at characterizing tissue, distinguishing solid from cystic components, and identifying the exact origin of a pelvic mass. In one study of 50 ovarian and adnexal masses, ultrasound could identify the origin of only 46% of them, while MRI identified the origin in 88%.
MRI doesn’t replace ultrasound as a first-line tool because it’s more expensive and time-consuming. But for indeterminate masses, those that don’t clearly fit into the “obviously benign” or “obviously suspicious” categories, it provides the detail needed to guide the next decision.
Age and Genetic Risk Factors
Your age and menopausal status significantly affect how doctors interpret an ovarian cyst. Before menopause, ovarian cysts are extremely common and almost always benign. They form as part of your normal monthly cycle. After menopause, the ovaries stop producing eggs, so new cysts are less expected. A complex cyst found after menopause gets more scrutiny, though even then, most turn out to be benign.
Family history and genetics also matter. Women who carry a harmful BRCA1 gene mutation have a 39% to 58% lifetime risk of developing ovarian cancer. For BRCA2 carriers, the lifetime risk is 13% to 29%. These numbers are dramatically higher than the general population risk of about 1.2%. If you have a known BRCA mutation or a strong family history of ovarian or breast cancer, your doctor will evaluate any ovarian mass more aggressively.
Why Biopsies Aren’t Used for Ovarian Cysts
Unlike a breast lump or a skin lesion, ovarian cysts are not biopsied with a needle before surgery. Puncturing a potentially cancerous ovarian mass risks spilling malignant cells into the abdominal cavity, which could spread the cancer and worsen the prognosis. For this reason, the only way to get a definitive tissue diagnosis is to surgically remove the cyst or the entire ovary and examine it under a microscope.
If the cyst appears low-risk, surgery is often done through small incisions using a camera (laparoscopy), with a shorter recovery of one to two weeks. If cancer is a serious concern based on imaging and blood work, the surgeon may recommend a larger incision to avoid rupturing the mass during removal. In confirmed cancer cases, the surgery may involve removing both ovaries, the fallopian tubes, the uterus, and the cervix, depending on how far the disease has spread. This is why getting an accurate pre-surgical assessment matters so much: it determines who performs your surgery and how extensive the operation needs to be.
How the Pieces Fit Together
No single test tells you whether an ovarian cyst is cancerous. Doctors combine ultrasound appearance, blood markers, your age, menopausal status, symptoms, and genetic history into an overall risk estimate. A simple cyst in a 30-year-old with normal blood work is managed with watchful waiting, often just a follow-up ultrasound in six to eight weeks. A complex, solid mass in a 65-year-old with elevated CA-125 and a family history of ovarian cancer gets an urgent referral to a gynecologic oncologist.
Most women who go through this process learn their cyst is benign. But the evaluation exists precisely to catch the small percentage that aren’t, at a stage when treatment is most effective. If your doctor recommends additional imaging, blood tests, or surgical removal, it typically reflects a cautious approach rather than a strong suspicion of cancer.